Pharming Intellectual Property B.V. v. Pharmington Pharma Limited Liability Company, dedc:1:2022cv01325

pharmaceutical products for the treatment of hereditary angioedema, also referred to as HAE;

pharmaceutical products for the treatment of hereditary angioedema, also referred to as HAE;

Pharmaceutical preparations and substances for the treatment of viral, [ metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, ] oncological, [ hepatological, ophthalmic, ] respiratory, neurological, gastrointestinal, hormonal, [ dermatological, psychiatric, ] genetic disorders and immune system related diseases and disorders;

Pharmaceutical preparations and substances for the treatment of viral, [ metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, ] oncological, [ hepatological, ophthalmic, ] respiratory, neurological, gastrointestinal, hormonal, [ dermatological, psychiatric, ] genetic disorders and immune system related diseases and disorders;

Pharmaceutical preparations and substances for the treatment of viral, [ metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, ] oncological, [ hepatological, ophthalmic, ] respiratory, neurological, gastrointestinal, hormonal, [ dermatological, psychiatric, ] genetic disorders and immune system related diseases and disorders [, except not including pharmaceutical preparations to treat or prevent obesity; pharmaceutical preparations for weight management, weight loss and the maintenance of weight loss; pharmaceutical preparations for the treatment and prevention of diabetes; pharmaceutical preparations for the promotion of smoking cessation; pharmaceutical preparations for the treatment and prevention of drug and alcohol abuse ];